{
    "medicine_id": "81cc9fd52cac9e744d8269a3146848317916a106",
    "platform_id": "DB00337",
    "metadata": {
        "name": "Elidel 10 mg 1g Cream",
        "composition": "10 mg 1g Pimecrolimus",
        "clinical_particulars": {
            "therapeutic_indications": "For treatment of mild to moderate atopic dermatitis",
            "contraindications": {
                "disease": "Side effects include burning sensation irritation pruritus erythema and skin infections at the application site",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Pimecrolimus is a chemical that is used to treat atopic dermatitis eczema Atopic dermatitis is a skin condition characterized by redness itching scaling and inflammation of the skin The cause of atopic dermatitis is not known however scientists believe that it may be due to activation of the immune system by various environmental or emotional triggers Scientists do not know exactly how pimecrolimus reduces the manifestations of atopic dermatitis but pimecrolimus reduces the action of T cells and mast cells which are part of the immune system and contribute to responses of the immune system Pimecrolimus prevents the activation of T cells by blocking the effects of chemicals cytokines released by the body that stimulate T cells Pimecrolimus also reduces the ability of mast cells to release chemicals that promote inflammation",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00005",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Etanercept"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa n1"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa n3"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Anakinra"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon gamma 1b"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa 2a Recombinant"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Gemtuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pegaspargase"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Infliximab"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon beta 1b"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfacon 1"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Rituximab"
                    },
                    {
                        "drugbank-id": "DB00074",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Basiliximab"
                    },
                    {
                        "drugbank-id": "DB00075",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Muromonab"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ibritumomab tiuxetan"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Alemtuzumab"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00092",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Alefacept"
                    },
                    {
                        "drugbank-id": "DB00095",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Efalizumab"
                    },
                    {
                        "drugbank-id": "DB00098",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Antithymocyte immunoglobulin rabbit"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00108",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Natalizumab"
                    },
                    {
                        "drugbank-id": "DB00111",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Daclizumab"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Bevacizumab"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Phenylalanine"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Flunisolide"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cladribine"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Carmustine"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Amsacrine"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Bleomycin"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Chlorambucil"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Raltitrexed"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mitomycin"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Floxuridine"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Indomethacin"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tioguanine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dexrazoxane"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Streptozocin"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Trifluridine"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Gemcitabine"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Epirubicin"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Lenalidomide"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Altretamine"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vincristine"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Propylthiouracil"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pentostatin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Methotrexate"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluocinolone acetonide"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Linezolid"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Imatinib"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Clofarabine"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Prednisone"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pemetrexed"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fludrocortisone"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mycophenolate mofetil"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tretinoin"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Methimazole"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dacarbazine"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Temozolomide"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Penicillamine"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Prednisolone"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Sirolimus"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mechlorethamine"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Azacitidine"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Carboplatin"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Methylprednisolone"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cytarabine"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Azathioprine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Busulfan"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mycophenolic acid"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Topotecan"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mercaptopurine"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Melphalan"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fludarabine"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Leflunomide"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Flucytosine"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Capecitabine"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Trilostane"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ifosfamide"
                    },
                    {
                        "drugbank-id": "DB01196",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Estramustine"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Lomustine"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dasatinib"
                    },
                    {
                        "drugbank-id": "DB01257",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Eculizumab"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Decitabine"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Nelarabine"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Corticotropin"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ciclesonide"
                    },
                    {
                        "drugbank-id": "DB01423",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Stepronin"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB01816",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Castanospermine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB02806",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with 2 Methoxyethanol"
                    },
                    {
                        "drugbank-id": "DB03523",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Brequinar"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Thiotepa"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Aldosterone"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pirfenidone"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Interferon alfa"
                    },
                    {
                        "drugbank-id": "DB05259",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05260",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Gallium nitrate"
                    },
                    {
                        "drugbank-id": "DB05459",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Briakinumab"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Human interferon omega 1"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06612",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mepolizumab"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06643",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Denosumab"
                    },
                    {
                        "drugbank-id": "DB06662",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Abetimus"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB06681",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Belatacept"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Bendamustine"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pralatrexate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08868",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fingolimod"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ruxolitinib"
                    },
                    {
                        "drugbank-id": "DB08879",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Belimumab"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ponatinib"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08908",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dimethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09033",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vedolizumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ibrutinib"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Idelalisib"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Olaparib"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tixocortol"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB09312",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Antilymphocyte immunoglobulin horse"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluprednisolone"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Melengestrol"
                    },
                    {
                        "drugbank-id": "DB11569",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ixekizumab"
                    },
                    {
                        "drugbank-id": "DB11580",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ravulizumab"
                    },
                    {
                        "drugbank-id": "DB11616",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Pirarubicin"
                    },
                    {
                        "drugbank-id": "DB11693",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Voclosporin"
                    },
                    {
                        "drugbank-id": "DB11708",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Peficitinib"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Sarilumab"
                    },
                    {
                        "drugbank-id": "DB11776",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Brodalumab"
                    },
                    {
                        "drugbank-id": "DB11803",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Sirukumab"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Baricitinib"
                    },
                    {
                        "drugbank-id": "DB11834",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Guselkumab"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB11988",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ocrelizumab"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Triptolide"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Ozanimod"
                    },
                    {
                        "drugbank-id": "DB12617",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mizoribine"
                    },
                    {
                        "drugbank-id": "DB12692",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Gusperimus"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB12902",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Trofosfamide"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Doxifluridine"
                    },
                    {
                        "drugbank-id": "DB12991",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Deoxyspergualin"
                    },
                    {
                        "drugbank-id": "DB12996",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Acteoside"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13068",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with 9 N methyl L isoleucine cyclosporin A"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluocortin"
                    },
                    {
                        "drugbank-id": "DB13241",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Begelomab"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluperolone"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluclorolone"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14219",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Monomethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB14762",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Risankizumab"
                    },
                    {
                        "drugbank-id": "DB14919",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Rozanolixizumab"
                    },
                    {
                        "drugbank-id": "DB15253",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Bleselumab"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Hydrocortisone butyrate"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Desoximetasone"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mometasone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluorometholone"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may increase the immunosuppressive activities of Pimecrolimus"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The serum concentration of Voxelotor can be increased when it is combined with Pimecrolimus"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Pimecrolimus can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The serum concentration of Levamlodipine can be increased when it is combined with Pimecrolimus"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Tramadol can be decreased when combined with Pimecrolimus"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Pimecrolimus"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Pimecrolimus can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Pimecrolimus can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Pimecrolimus"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with Pimecrolimus"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Pimecrolimus"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of infection can be increased when Pimecrolimus is combined with Inebilizumab"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Pimecrolimus can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Pimecrolimus can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}